DenmarkDenmark

Novozymes sets sail for maritime biofuels

23.12.2011

Copenhagen - An alliance of giants will take a thorough look into biofuels for the maritime sector. The leading enzyme producer Novozymes will team up with parts of the Danish shipping industry, including the world’s largest shipping company, A.P. Moller - Maersk. The newly established alliance will work on converting biomass into sugar and onward into biofuels that can be utilised in the maritime sector. “We've been working to develop the biotechnological solutions that enable biomass to be converted into sugar and sustainable bioethanol for land transportation for many years", said Lars Hansen, Vice President of Region Europe at Novozymes. "It's therefore natural for us to contribute our knowledge to this new project."
The project is to be headed by Professor Claus Felby of the University of Copenhagen and is set to run for 5 years. Other participants in the project include DTU (the Technical University of Denmark), Haldor Topsøe, MAN Diesel & Turbo and DONG Energy.
The maritime sector accounts for approximately 10% of global transport energy consumption. Maritime transportation represents global man-made CO2 emissions equivalent to the carbon footprint of a country such as Germany, says Novozymes.

DenmarkDenmark

09.12.2009

Copenhagen – Synthetic rubber from biomass could soon replace the petrochemically-produced raw materials currently used in the industry. At the United Nations Climate Change Conference in Copenhagen, Goodyear, one of the world’s...

DenmarkDenmark

20.09.2009

Bagsvaerd – Danish biotech company Novozymes A/S is gearing up to seize a pole position in China. “We have been invited by the National Development and Reform Commission (NDRC) to create a roadmap for cellulosic fuel for China,”...

DenmarkDenmark

19.09.2009

Ballerup – Danish pharma company LEO Pharma A/S has acquired Australian dermatology company Peplin Inc. for US$287.5m in cash. In addition, LEO will provide Peplin with access to a loan facility to fund ongoing operations until...

DenmarkDenmark

13.07.2009

Copenhagen – In June, the Faculty of Health Sciences at the University of Copenhagen opened the doors on its new research center, the Novo Nordisk Foundation Center for Protein Research (CPR). The latest facility was built with a...

DenmarkDenmark

13.07.2009

Bagsvaerd – Danish Group Novo A/S announced the start of its Novo Growth Equity fund in June. The fund will invest US$200m annually in late stage private and small cap public life sciences companies. Novo Growth Equity is...

DenmarkDenmark

08.06.2009

Copenhagen – The Danish National Advanced Technology Foundation has announced a grant to biotech company Exiqon A/S and a consortium of Danish hospitals and universities. They will receive funding totalling DKK 24m (EUR3.2m) for...

DenmarkDenmark

08.06.2009

Copenhagen – In a 10-3 vote, the Oncologic Drugs Advisory Committee (ODAC) at the US Food and Drug Administration has released a positive opinion for monoclonal antibody Arzerra (ofatumumab), made by Danish biotech Genmab A/S....

DenmarkDenmark

06.06.2009

Copenhagen – Denmark’s biotech industry has plenty of drugs under develop­ment despite the worldwide economic downturn. But according to an Ernst & Young report, a current lack of capital is making it necessary for companies in...

Displaying results 41 to 50 out of 194

< Previous 41-50 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-denmark/browse/4/article/novozymes-sets-sail-for-maritime-biofuels.html

Events

All Events

Stock list

All quotes

TOP

  • CO.DON3.13 EUR5.03%
  • 4SC1.06 EUR3.92%
  • SANTHERA88.65 CHF2.78%

FLOP

  • CYTOS0.19 CHF-9.52%
  • WILEX2.13 EUR-6.99%
  • FORMYCON8.03 EUR-5.42%

TOP

  • PAION3.18 EUR30.9%
  • CO.DON3.13 EUR26.2%
  • FORMYCON8.03 EUR17.7%

FLOP

  • CYTOS0.19 CHF-24.0%
  • ADDEX3.13 CHF-21.4%
  • EVOTEC3.06 EUR-18.2%

TOP

  • SANTHERA88.65 CHF2088.9%
  • PAION3.18 EUR238.3%
  • CO.DON3.13 EUR229.5%

FLOP

  • CYTOS0.19 CHF-95.1%
  • 4SC1.06 EUR-45.4%
  • THERAMETRICS0.08 CHF-42.9%

No liability assumed, Date: 29.09.2014


Current issue

All issues

Product of the week

Products